aTYR PHARMA (ATYR) Capital Leases (2022 - 2026)
aTYR PHARMA's (ATYR) quarterly Capital Leases came in at $151000.0 in Q1 2026, down 79.79% YoY from $747000.0 in Q1 2025, and down 41.7% on a QoQ basis from $259000.0 in Q4 2025.
aTYR PHARMA (ATYR) Capital Leases (2022 - 2026) Analysis & Trends
aTYR PHARMA (ATYR) has 5 years of Capital Leases data on file, last reported at $151000.0 in Q1 2026.
- Quarterly Capital Leases fell 79.79% year-over-year to $151000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $151000.0 (down 79.79% YoY) and the FY2025 annual result came in at $259000.0, down 70.8% from the prior year.
- Capital Leases slipped to $151000.0 in Q1 2026, from $259000.0 in the prior quarter.
- In the past five years, Capital Leases ranged from a high of $1.6 million in Q1 2023 to a low of $151000.0 in Q1 2026.
- A 5-year average of $901000.0 and a median of $947000.0 in 2022 frame the typical range for Capital Leases.
- Annual changes were most pronounced in 2023 — Capital Leases jumped 411.74% — and 2026, when it sank 79.79%.
- Tracing ATYR's Capital Leases over 5 years: stood at $1.0 million in 2022, then jumped by 41.81% to $1.4 million in 2023, then sank by 37.89% to $887000.0 in 2024, then tumbled by 70.8% to $259000.0 in 2025, then sank by 41.7% to $151000.0 in 2026.
- The last three Capital Leases figures came in at $151000.0 (Q1 2026), $259000.0 (Q4 2025), and $398000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | aTYR PHARMA | 49.54 Mn | -7.87 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 36,000.00 |
| Mar 31, 2026 | 151,000.00 |
| Dec 31, 2025 | 259,000.00 |
| Sep 30, 2025 | 398,000.00 |
| Jun 30, 2025 | 602,000.00 |
| Mar 31, 2025 | 747,000.00 |
| Dec 31, 2024 | 887,000.00 |
| Sep 30, 2024 | 1.03 Mn |
| Jun 30, 2024 | 1.16 Mn |
| Mar 31, 2024 | 1.30 Mn |
| Dec 31, 2023 | 1.43 Mn |
| Sep 30, 2023 | 1.44 Mn |
| Jun 30, 2023 | 1.53 Mn |
| Mar 31, 2023 | 1.57 Mn |
| Dec 31, 2022 | 1.01 Mn |
| Sep 30, 2022 | 618,000.00 |
| Jun 30, 2022 | 298,000.00 |